Nuclear Imaging Agents Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033

Nuclear Imaging Systems Market Report Overview

The nuclear imaging systems market size was valued at $1.07 billion in 2023. The nuclear imaging systems market will grow at a CAGR of more than 2% from 2023 to 2033. Nuclear Imaging is a non-invasive medical technique that uses radioactive tracers (generally F-18 Fluorodeoxyglucose) to assess and diagnose bodily functions and diseases, including cancers, cardiac diseases, gastrointestinal, endocrine, and neurological diseases.

Nuclear Imaging Systems Market Outlook 2023-2033 ($ Billion)

Buy the Full Report for More Insights on the Nuclear Imaging Systems Market Forecast, Download a Free Sample Report

The nuclear imaging systems market research report provides an in-depth analysis of the market behavior, which will help identify market trends within diagnostic imaging therapeutic areas. The report has extensively covered regional-wise quantitative data, highlighting the number of nuclear imaging systems across labs, which will help in identifying untapped market opportunities. The nuclear imaging systems market model also discusses the detailed impact of COVID-19 on the nuclear imaging systems market for 2020 and beyond.

Nuclear Imaging Systems Market Dynamics

The market has been continuously growing since the last decade due to technical advancements and applied research. An increase in the nuclear Imaging market during the forecast period due to the growing aging population with cardiac and neurological ailments and increasing incidence of cancer among young and old population will drive the market growth. However, PET systems may not be replaced by SPECT systems even if they are economic and technically advanced, because PET systems give better-resolution images with less scatter and attenuation. The half-life of radiotracer is six hours, which further increases the time of imaging. Unlike PET systems, SPECT systems produce qualitative images that can be uncertain.

Buy the Full Report for Additional Nuclear Imaging Systems Market Dynamics, Download a Free Sample Report

Nuclear Imaging Systems Market Segments

The key segments in the nuclear imaging systems market are PET imaging agents and SPECT imaging agents. In 2023, the SPECT imaging agents segment dominated the market share. The segment will continue to dominate the market share throughout the projected period.

Nuclear Imaging Systems Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segment-Wise Insights about the Nuclear Imaging Systems Market, Download a Free Sample Report

Nuclear Imaging Systems Market Segmentation by Regions

The key regions in the nuclear imaging systems market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South and Central America. In 2023, North America was the leading regional market. The North American nuclear imaging systems market growth is mainly owing to the performance of the US market. The market in the region will continue to grow due to the increasing population with cancers and cardiac and neurological diseases. Furthermore, factors such as advances in research and technology, better access to healthcare facilities, availability of skilled professionals, better patient awareness, and improved health insurance policies are expected to drive the market growth.

Nuclear Imaging Systems Market Analysis by Regions, 2023 (%)

Buy the Full Report for More Regional Insights in the Nuclear Imaging Systems Market, Download A Free Sample Report

Nuclear Imaging Systems Market – Competitive Landscape

The key companies in the nuclear imaging systems market are Cardinal Health Inc, GE Healthcare, Advanced Accelerator Applications SA, Bracco Diagnostics Inc, and Lantheus Holdings Inc among others. In 2023, GE Healthcare accounted for the highest nuclear imaging systems market share and value.

Nuclear Imaging Systems Market Analysis by Companies, 2023 (%)

Buy the Full Report for More Company-Wise Insights into the Nuclear Imaging Systems Market, Download a Free Sample Report

Segments Covered in this Report.

Nuclear Imaging Systems Segment Outlook ($ Million, 2015-2033)

• PET Imaging Agents
  • Copper-Based PET Imaging Agents
  • Fluorine-Based PET Imaging Agents
  • Gallium-68-Based PET Imaging Agents
  • Rubidium-Based PET Imaging Agents
• SPECT Imaging Agents
  • Gallium-67-Based SPECT Imaging Agents
  • Indium-Based SPECT Imaging Agents
  • Iodine-Based SPECT Imaging Agents
  • Lutetium-Based SPECT Imaging Agents
  • Technetium-Based SPECT Imaging Agents
  • Thallium-Based SPECT Imaging Agents

Nuclear Imaging Systems Regional Outlook ($ Million, 2015-2033)

• Asia-Pacific
• Europe
• Middle East and Africa
• North America
• South and Central America

Key Inclusions of the market model are –

Currently marketed nuclear imaging systems market and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total nuclear imaging systems market revenue by segment and market outlooks from 2015-2033.
• Market-level data on units, average selling prices, and market values.

Global, Regional and Country level market specific insights:

• Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
• SWOT analysis for the Nuclear imaging systems market.
• Competitive dynamics insights and trends provided for the nuclear imaging systems market.

Get an in-depth understanding of consumer behavior through the market access segment and the overview of the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.

• Country-specific overview of the healthcare system.
• Country-specific reimbursement policies.
• Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, the report helps determine market trends through real-world data sources including government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Cardinal Health Inc, GE Healthcare, Advanced Accelerator Applications SA, Bracco Diagnostics Inc, Lantheus Holdings Inc and Others.

Countries covered – United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. The model will benefit the following stakeholders:

• CMO executives who must have a deep understanding of the nuclear imaging systems marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

• Understand the impact of COVID-19 on nuclear imaging systems.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving nuclear imaging systems.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the nuclear imaging systems market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific nuclear imaging systems market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.